Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: findings from the Icatibant Outcome Survey

BACKGROUND: Patients with hereditary angioedema (HAE) due to C1-inhibitor deficiency (C1-INH-HAE) experience recurrent attacks of cutaneous or submucosal edema that may be frequent and severe; prophylactic treatments can be prescribed to prevent attacks. However, despite the use of long-term prophyl...

Descripción completa

Detalles Bibliográficos
Autores principales: Aberer, Werner, Maurer, Marcus, Bouillet, Laurence, Zanichelli, Andrea, Caballero, Teresa, Longhurst, Hilary J., Perrin, Amandine, Andresen, Irmgard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497380/
https://www.ncbi.nlm.nih.gov/pubmed/28690642
http://dx.doi.org/10.1186/s13223-017-0203-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497380/
https://www.ncbi.nlm.nih.gov/pubmed/28690642
http://dx.doi.org/10.1186/s13223-017-0203-z

Ejemplares similares